New Insights into Development of Transglutaminase 2 Inhibitors as Pharmaceutical Lead Compounds
Transglutaminase 2 (EC 2.3.2.13; TG2 or TGase 2) plays important roles in the pathogenesis of many diseases, including cancers, neurodegeneration, and inflammatory disorders. Under normal conditions, however, mice lacking TGase 2 exhibit no obvious abnormal phenotype. TGase 2 expression is induced b...
Main Author: | Soo-Youl Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-10-01
|
Series: | Medical Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-3271/6/4/87 |
Similar Items
-
Use of transglutaminases in foods and potential utilization of plants as a transglutaminase source – Review
by: Fernando Bittencourt Luciano, et al.
Published: (2012-09-01) -
Use of transglutaminases in foods and potential utilization of plants as a transglutaminase source – Review
by: Fernando B. Luciano, et al.
Published: (2012-11-01) -
Effect of Rosemary Transglutaminase on Yoghurt Fortified with Whey Protein Isolate
by: Ibrahim Osama, et al.
Published: (2017-12-01) -
Changes in Morphology and Activity of Transglutaminase Following Cross-Linking and Immobilization on a Polypropylene Microporous Membrane
by: Lei Qian, et al.
Published: (2011-12-01) -
Nutrient and specification enhancement of fortified Asian noodles by chickpea flour substitution and transglutaminase treatment
by: Lihong Han, et al.
Published: (2021-01-01)